Discover
CLLS
Cellectis S.A.
1.53
1 x 2.80
1 x 2.99
bid
ask
+
0.07
4.79%
1 @ 07:30 PM
1.53 +0.00 (0.00%)
| Ytd | -68.39% | |
| 1y | -51.58% |
1.45
day range
1.55
1.38
52 week range
5.35
| Open | 1.48 | Prev Close | 1.46 | Low | 1.45 | High | 1.55 | Mkt Cap | 154.10M |
| Vol | 249.56K | Avg Vol | 66.35K | EPS | -0.64 | P/E | N/A | Forward P/E | -2.07 |
| Beta | 3.20 | Short Ratio | 1.41 | Inst. Own | 16.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 2.90 | 200-d Avg | 3.59 | 1yr Est | 6.67 |
| Income Statement | |||
| Total Revenue | 6.90M | ||
| Revenues (USD) | 6.90M | ||
| Gross Profit | 6.90M | ||
| Operating Expenses | 30.43M | ||
| Research and Development Expense | 24.98M | ||
| Selling, General and Administrative Expense | 5.74M | ||
| Operating Income | -23.52M | ||
| Interest Expense | 2.95M | ||
| Income Tax Expense | 26.00K | ||
| Net Income | -21.82M | ||
| Net Income Common Stock | -21.82M | ||
| Net Income Common Stock (USD) | -21.82M | ||
| Consolidated Income | -21.82M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -18.84M | ||
| Earning Before Interest & Taxes (USD) | -18.84M | ||
| Weighted Average Shares | 100.65M | ||
| Weighted Average Shares Diluted | 100.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 35.59M | ||
| Cash and Equivalents (USD) | 35.59M | ||
| Investments | 135.98M | ||
| Investments Current | 131.26M | ||
| Investments Non-Current | 4.72M | ||
| Trade and Non-Trade Receivables | 12.60M | ||
| Current Assets | 184.42M | ||
| Property, Plant & Equipment Net | 53.99M | ||
| Total Assets | 267.37M | ||
| Debt Current | 14.27M | ||
| Total Debt | 104.28M | ||
| Current Liabilities | 134.96M | ||
| Debt Non-Current | 90.01M | ||
| Total Liabilities | 226.30M | ||
| Accumulated Retained Earnings (Deficit) | -303.93M | ||
| Accumulated Other Comprehensive Income | -32.68M | ||
| Shareholders Equity | 41.07M | ||
| Shareholders Equity (USD) | 41.07M | ||
| Assets Non-Current | 82.95M | ||
| Total Debt (USD) | 104.28M | ||
| Deferred Revenue | 90.92M | ||
| Goodwill and Intangible Assets | 1.12M | ||
| Liabilities Non-Current | 91.34M | ||
| Trade and Non-Trade Payables | 18.20M | ||
| Tax Assets | 382.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.41M | ||
| Net Cash Flow from Financing | -3.25M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.18M | ||
| Capital Expenditure | -253.00K | ||
| Issuance (Purchase) of Equity Shares | 174.00K | ||
| Issuance (Repayment) of Debt Securities | -3.43M | ||
| Net Cash Flow from Investing | 18.71M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 18.97M | ||
| Net Cash Flow from Operations | -14.28M | ||
| Effect of Exchange Rate Changes on Cash | -427.00K | ||
| Share Based Compensation | 2.29M | ||